Effects of probiotics on gut microbiota: Mechanisms of intestinal immunomodulation and neuromodulation

Therapeutic Advances in Gastroenterology

Volumn 6, Issue 1, 2013, Pages 39-51

  Hemarajata, Peera ^a   Versalovic, James ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Diet; Gut microbiota; Immunomodulation; Lactobacillus; Nervous system; Probiotics

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIBIOTIC AGENT; GLUTAMIC ACID; HISTAMINE; HISTIDINE; HISTIDINE DECARBOXYLASE; INTERLEUKIN 10; INTERLEUKIN 12; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; BACTERIAL COLONIZATION; BACTEROIDES FRAGILIS; BACTEROIDES THETAIOTAOMICRON; BACTEROIDETES; BIFIDOBACTERIUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; DIARRHEA; DIETARY FIBER; DIETARY INTAKE; DISEASE PREDISPOSITION; DRUG MECHANISM; ENTERITIS; ENTEROPATHY; FECES MICROFLORA; HUMAN; IMMUNOMODULATION; INTESTINE EPITHELIUM; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MICROBIAL COMMUNITY; MICROBIAL METABOLISM; NEUROMODULATION; NONHUMAN; NUTRITION; PAIN; PERIPHERAL NERVOUS SYSTEM; PHENOTYPE; PREVOTELLA; PRIORITY JOURNAL; REVIEW; RUMINOCOCCUS; STREPTOCOCCUS THERMOPHILUS; SYSTEMIC DISEASE; TRANSCRIPTOMICS;

EID: 84871670020     PISSN: 1756283X     EISSN: 17562648     Source Type: Journal    
DOI: 10.1177/1756283X12459294     Document Type: Review

References (73)

1. Abubucker S. Segata N. Goll J. Schubert A. Izard J. Cantarel B. et al. (2012) Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput Biol 8: e1002358.
2. Artis D. (2008) Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 8: 411–420.
3. Arumugam M. Raes J. Pelletier E. Le Paslier D. Yamada T. Mende D. et al. (2011) Enterotypes of the human gut microbiome. Nature 473: 174–180.
4. Bajaj J. Ridlon J. Hylemon P. Thacker L. Heuman D. Smith S. et al. (2011) Linkage of gut microbiome with cognition in hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol 302: G168–G175.
5. Berer K. Mues M. Koutrolos M. Rasbi Z. Boziki M. Johner C. et al. (2011) Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479: 538–541.
6. Bienenstock J. Collins S. (2010) 99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Psycho-Neuroimmunology and the Intestinal Microbiota: Clinical observations and basic mechanisms. Clin Exp Immunol 160: 85–91.
7. Bienenstock J. Forsythe P. Karimi K. Kunze W. (2010) Neuroimmune aspects of food intake. Intl Dairy J 20: 253–258.
8. Bravo J. Forsythe P. Chew M. Escaravage E. Savignac H. Dinan T. et al. (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108: 16050–16055.
9. Bron P. van Baarlen P. Kleerebezem M. (2011) Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol 10: 66–78.
10. Cani P. Delzenne N. (2009) Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol 9: 737–743.
11. Claus S. Tsang T. Wang Y. Cloarec O. Skordi E. Martin F. et al. (2008) Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol Syst Biol 4: 219.
12. Collado M. Meriluoto J. Salminen S. (2007) Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Lett Appl Microbiol 45: 454–460.
13. Cox M. Huang Y. Fujimura K. Liu J. McKean M. Boushey H. et al. (2010) Lactobacillus casei abundance is associated with profound shifts in the infant gut microbiome. PloS ONE 5: e8745.
14. Eisenhauer N. Scheu S. Jousset A. (2012) Bacterial diversity stabilizes community productivity. PloS ONE 7: e34517.
15. Food and Agriculture Organization of the United Nations, World Health Organization, Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, and Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food (2006) Probiotics in food: health and nutritional properties and guidelines for evaluation. In Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, Cordoba, Argentina, 1–4 October 2001 [and] Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food, London, O.N., Canada, 30 April –1 May 2002. Rome: Food and Agriculture Organization of the United Nations, World Health Organization.
16. Forno E. Onderdonk A. McCracken J. Litonjua A. Laskey D. Delaney M. et al. (2008) Diversity of the gut microbiota and eczema in early life. Clin Mol Allergy 6: 11.
17. Forsythe P. Sudo N. Dinan T. Taylor V. Bienenstock J. (2009) Mood and gut feelings. Brain Behav Immun 24: 9–16.
18. Frank D. Zhu W. Sartor R. Li E. (2011) Investigating the biological and clinical significance of human dysbioses. Trends Microbiol 19: 427–434.
19. Gill S. Pop M. Deboy R. Eckburg P. Turnbaugh P. Samuel B. et al. (2006) Metagenomic analysis of the human distal gut microbiome. Science 312: 1355–1359.
20. Goodman A. Kallstrom G. Faith J. Reyes A. Moore A. Dantas G. et al. (2011) Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci U S A 108: 6252–6257.
21. Gosalbes M. Durban A. Pignatelli M. Abellan J. Jimenez-Hernandez N. Perez-Cobas A. et al. (2011) Metatranscriptomic approach to analyze the functional human gut microbiota. PloS ONE 6: e17447.
22. Higuchi T. Hayashi H. Abe K. (1997) Exchange of glutamate and gamma-aminobutyrate in a Lactobacillus strain. J Bacteriol 179: 3362–3364.
23. Jarchum I. Pamer E. (2011) Regulation of innate and adaptive immunity by the commensal microbiota. Curr Opin Immunol 23: 353–360.
24. Jones S. Versalovic J. (2009) Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol 9: 35.
25. Jumpertz R. Le D. Turnbaugh P. Trinidad C. Bogardus C. Gordon J. et al. (2011) Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr 94: 58–65.
26. Kamiya T. Wang L. Forsythe P. Goettsche G. Mao Y. Wang Y. et al. (2006) Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague–Dawley rats. Gut 55: 191–196.
27. Karin M. Lawrence T. Nizet V. (2006) Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124: 823–835.
28. Ki Cha B. Mun Jung S. Hwan Choi C. Song I. Woong Lee H. Joon Kim H. et al. (2011) The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Clin Gastroenterol 46: 220–227.
29. Kurokawa K. Itoh T. Kuwahara T. Oshima K. Toh H. Toyoda A. et al. (2007) Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res 14: 169–181.
30. Larsen N. Vogensen F. van Den Berg F. Nielsen D. Andreasen A. Pedersen B. et al. (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PloS ONE 5: e9085.
31. Larsson E. Tremaroli V. Lee Y. Koren O. Nookaew I. Fricker A. et al. (2012) Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through Myd 88. Gut, 61: 1124–1131.
32. Lavasani S. Dzhambazov B. Nouri M. Fak F. Buske S. Molin G. et al. (2010) A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PloS ONE 5: e9009.
33. Lederberg J. McCray A. (2001) ‘Ome sweet’ omics: a genealogical treasury of words. The Scientist 15: 8.
34. Lee B. Bak Y. (2011) Irritable bowel syndrome, gut microbiota and probiotics. J Neurogastroenterol Motil 17: 252–266.
35. Li H. Cao Y. (2010) Lactic acid bacterial cell factories for gamma-aminobutyric acid. Amino Acids 39: 1107–1116.
36. Lin Y. Thibodeaux C. Pena J. Ferry G. Versalovic J. (2008) Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm Bowel Dis 14: 1068–1083.
37. Liu Y. Fatheree N. Mangalat N. Rhoads J. (2010) Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 299: G1087–G1096.
38. Livingston M. Loach D. Wilson M. Tannock G. Baird M. (2009) Gut commensal Lactobacillus reuteri 100–23 stimulates an immunoregulatory response. Immunol Cell Biol 88: 99–102.
39. Manichanh C. Rigottier-Gois L. Bonnaud E. Gloux K. Pelletier E. Frangeul L. et al. (2006) Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55: 205–211.
40. Mayer E. (2011) Gut feelings: the emerging biology of gut–brain communication. Nat Rev Neurosci 12: 453–466.
41. McNulty N. Yatsunenko T. Hsiao A. Faith J. Muegge B. Goodman A. et al. (2011) The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med 3: 106.
42. Metchnikoff E. Mitchell P. (1907) The Prolongation of Life : Optimistic Studies. London: W. Heinemann/New York: GP: Putnam's Sons.
43. Neufeld K. Foster J. (2009) Effects of gut microbiota on the brain: implications for psychiatry. J Psychiatry Neurosci 34: 230–231.
44. Nobaek S. Johansson M. Molin G. Ahrne S. Jeppsson B. (2000) Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 95: 1231–1238.
45. O'Shea E. Cotter P. Stanton C. Ross R. Hill C. (2011) Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid. Int J Food Microbiol 152: 189–205.
46. O'Toole P. Cooney J. (2008) Probiotic bacteria influence the composition and function of the intestinal microbiota. Interdiscip Perspect Infect Dis 2008: 175–285.
47. Ochoa-Reparaz J. Mielcarz D. Begum-Haque S. Kasper L. (2011) Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. Ann Neurol 69: 240–247.
48. Ochoa-Reparaz J. Mielcarz D. Ditrio L. Burroughs A. Foureau D. Haque-Begum S. et al. (2009) Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol 183: 6041–6050.
49. Pena J. Li S. Wilson P. Thibodeau S. Szary A. Versalovic J. (2004) Genotypic and phenotypic studies of murine intestinal Lactobacilli: species differences in mice with and without colitis. Appl Environ Microbiol 70: 558–568.
50. Pena J. Rogers A. Ge Z. Ng V. Li S. Fox J. et al. (2005) Probiotic Lactobacillus spp. diminish helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infect Immun 73: 912–920.
51. Pendyala S. Walker J. Holt P. (2012) A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 142: 1100–1101.e2.
52. Peterson G. Allen C. Holling C. (1998) Ecological resilience, biodiversity, and scale. Ecosystems 1: 6–18.
53. Pflughoeft K. Versalovic J. (2012) Human microbiome in health and disease. Annu Rev Pathol 7: 99–122.
54. Preidis G. Saulnier D. Blutt S. Mistretta T. Riehle K. Major A. et al. (2012) Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine. FASEB J 26: 1960–1969.
55. Preidis G. Versalovic J. (2009) Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 136: 2015–2031.
56. Qin J. Li R. Raes J. Arumugam M. Burgdorf K. Manichanh C. et al. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59–65.
57. Saulnier D. Santos F. Roos S. Mistretta T. Spinler J. Molenaar D. et al. (2011) Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features. PloS ONE 6: e18783.
58. Sharma A. Lelic D. Brock C. Paine P. Aziz Q. (2009) New technologies to investigate the brain–gut axis. World J Gastroenterol 15: 182–191.
59. Sonnenburg J. Fischbach M. (2011) Community health care: therapeutic opportunities in the human microbiome. Sci Transl Med 3: 78ps12.
60. Spinler J. Taweechotipatr M. Rognerud C. Ou C. Tumwasorn S. Versalovic J. (2008) Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe 14: 166–171.
61. Su M. Schlicht S. Ganzle M. (2011) Contribution of glutamate decarboxylase in Lactobacillus reuteri to acid resistance and persistence in sourdough fermentation. Microb Cell Fact 10(Suppl. 1): S8.
62. The Human Microbiome Project Consortium (2012 a) Structure, function and diversity of the healthy human microbiome. Nature 486: 207–214.
63. The Human Microbiome Project Consortium (2012 b) A framework for human microbiome research. Nature 486: 215–221.
64. Thomas C. Hong T. van Pijkeren J. Hemarajata P. Trinh D. Hu W. et al. (2012) Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of Pka and Erk signaling. PloS ONE 7: e31951.
65. Thomas C. Versalovic J. (2010) Probiotics-host communication: modulation of signaling pathways in the intestine. Gut Microbes 1: 148–163.
66. Turnbaugh P. Hamady M. Yatsunenko T. Cantarel B. Duncan A. Ley R. et al. (2009) A core gut microbiome in obese and lean twins. Nature 457: 480–484.
67. Valeur N. Engel P. Carbajal N. Connolly E. Ladefoged K. (2004) Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol 70: 1176–1181.
68. van Baarlen P. Troost F. van der Meer C. Hooiveld G. Boekschoten M. Brummer R. et al. (2010) Human mucosal in vivo transcriptome responses to three Lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci U S A 108(Suppl. 1): 4562–4569.
69. Walter J. Ley R. (2011) The human gut microbiome: ecology and recent evolutionary changes. Annu Rev Microbiol 65: 411–429.
70. Wikoff W. Anfora A. Liu J. Schultz P. Lesley S. Peters E. et al. (2009) Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A 106: 3698–3703.
71. Wu G. Chen J. Hoffmann C. Bittinger K. Chen Y. Keilbaugh S. et al. (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 334: 105–108.
72. Yokote H. Miyake S. Croxford J. Oki S. Mizusawa H. Yamamura T. (2008) NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Am J Pathol 173: 1714–1723.
73. Zhang W. Wen K. Azevedo M. Gonzalez A. Saif L. Li G. et al. (2008) Lactic acid bacterial colonization and human rotavirus infection influence distribution and frequencies of monocytes/macrophages and dendritic cells in neonatal gnotobiotic pigs. Vet Immunol Immunopathol 121: 222–231.